Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)

Market Cap	53.20B +53.6%
Revenue (ttm)	4.27B +14.7%
Net Income	308.94M -35.1%
EPS	0.27 -36.7%
Shares Out	1.11B
PE Ratio	175.38
Forward PE	102.04
Dividend	0.42 (0.87%)
Ex-Dividend Date	n/a

Volume	2,244,530
Average Volume	3,132,282
Open	49.10
Previous Close	49.10
Day's Range	47.79 - 49.26
52-Week Range	29.13 - 62.65
Beta	-0.07
RSI	36.93
Earnings Date	Apr 13, 2026

About SHE:002653

Haisco Pharmaceutical Group Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in China. The company offers pharmaceutical products in the areas of anesthesia and analgesia, diabetes mellitus and complications, tumor, neuralgia, parenteral nutrition, cardio-cerebrovascular, digestive and respiratory, narcotic analgesics, endocrine system, enteral parenteral, nutrition, neuropsychiatric, cardiovascular, digestive liver, and other diseases. The company was formerly known as Xizang Haisco Pharmaceutical Group...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2000
• Employees: 5,337
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002653

Financial Performance

In 2024, SHE:002653's revenue was 3.72 billion, an increase of 10.92% compared to the previous year's 3.36 billion. Earnings were 395.46 million, an increase of 34.00%.